2020
DOI: 10.1101/2020.08.24.265090
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Induction of SARS-CoV-2 protein S-specific CD8+ T cells in the lungs of gp96-Ig-S vaccinated mice

Abstract: Given the aggressive spread of COVID-19-related deaths, there is an urgent public health need to support the development of vaccine candidates to rapidly improve the available control measures against SARS-CoV-2. To meet this need, we are leveraging our existing vaccine platform to target SARS-CoV-2. Here, we generated cellular heat shock chaperone protein, glycoprotein 96 (gp96), to deliver SARS-CoV-2 protein S (spike) to the immune system and to induce cell-mediated immune responses. We showed that our vacci… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 64 publications
(111 reference statements)
0
2
0
Order By: Relevance
“…In mice, the vaccine induced tissue-resident memory T (TRM) cells, capable of rapidly responding to infection in the tissue. It also elicited CD4+ and CD8+T cell responses that are specific to the S-protein epitopes in the lung interstitium and the airways [ 166 ]. Unlike other COVID-19 vaccines, this vaccine technology provided an approach to induce the desired cellular response directly in the target tissues.…”
Section: Status Of Covid-19 Vaccine Developmentmentioning
confidence: 99%
“…In mice, the vaccine induced tissue-resident memory T (TRM) cells, capable of rapidly responding to infection in the tissue. It also elicited CD4+ and CD8+T cell responses that are specific to the S-protein epitopes in the lung interstitium and the airways [ 166 ]. Unlike other COVID-19 vaccines, this vaccine technology provided an approach to induce the desired cellular response directly in the target tissues.…”
Section: Status Of Covid-19 Vaccine Developmentmentioning
confidence: 99%
“…This manuscript has been released as a pre-print at bioRxiv ( 65 ). We dedicate this work to the late Dr. Eckhard Podack.…”
Section: Acknowledgmentsmentioning
confidence: 99%